These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37241204)

  • 21. The Prevention of Medication-related Osteonecrosis of the Jaw.
    Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
    Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.
    Inchingolo F; Cantore S; Dipalma G; Georgakopoulos I; Almasri M; Gheno E; Motta A; Marrelli M; Farronato D; Ballini A; Marzullo A
    J Biol Regul Homeost Agents; 2017; 31(3):811-816. PubMed ID: 28958140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ).
    Miranda M; Gianfreda F; Raffone C; Antonacci D; Pistilli V; Bollero P
    Biomed Res Int; 2021; 2021():4948139. PubMed ID: 34095295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
    Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L
    Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report.
    Giudice A; Antonelli A; Muraca D; Fortunato L
    Indian J Dent Res; 2020; 31(5):813-818. PubMed ID: 33433526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Autologous Platelet Concentrates in the Treatment of Medication-Related Osteonecrosis of the Jaw.
    Ye P; Wei T; Lu ZY; Cai YJ
    J Craniofac Surg; 2021 Mar-Apr 01; 32(2):621-625. PubMed ID: 33704995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review of metastatic cancer presenting in osteonecrosis of the jaws (MC-ONJ) in patients undergoing antiresorptive and/or antiangiogenic therapy for skeletal-related adverse events.
    Sacco R; Woolley J; Yates J; Calasans-Maia MD; Akintola O; Patel V
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jun; 131(6):650-659. PubMed ID: 33518491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical treatment methods of medication-related osteonecrosis of the jaw. A systematic review.
    Zigmantavičius J; Kilinskaitė G; Kubilius R
    Stomatologija; 2022; 24(4):91-99. PubMed ID: 37154420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication related osteonecrosis of the jaws (MRONJ): Factors related to recurrence after treatment with surgery and platelet rich plasma (PRP) placement.
    Sánchez-Gallego Albertos C; Del Castillo Pardo de Vera JL; Viejo Llorente A; Cebrián Carretero JL
    Med Oral Patol Oral Cir Bucal; 2021 Nov; 26(6):e684-690. PubMed ID: 34704981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism, prevention, and treatment for medication-related osteonecrosis of the jaws.
    Pan J; Liu JY
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Jun; 39(3):245-254. PubMed ID: 34041871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous platelet-rich fibrin injections in the management of facial cutaneous sinus tracts secondary to medication-related osteonecrosis of the jaw.
    Bennardo F; Bennardo L; Del Duca E; Patruno C; Fortunato L; Giudice A; Nisticò SP
    Dermatol Ther; 2020 May; 33(3):e13334. PubMed ID: 32219975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
    Kawahara M; Kuroshima S; Sawase T
    Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteonecrosis of the jaw induced by bisphosphonates therapy in bone metastases patient: Case report and literature review.
    Hao L; Tian Z; Li S; Yan K; Xue Y
    Oral Oncol; 2022 May; 128():105852. PubMed ID: 35439709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging antiresorptive medications and their potential implications for dental surgeries.
    Aminoshariae A; Donaldson M; Horan M; Mackey SA; Kulild JC; Baur D
    J Am Dent Assoc; 2022 Jul; 153(7):649-658. PubMed ID: 35277242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series.
    Fernando de Almeida Barros Mourão C; Calasans-Maia MD; Del Fabbro M; Le Drapper Vieira F; Coutinho de Mello Machado R; Capella R; Miron RJ; Gomes Alves G
    J Stomatol Oral Maxillofac Surg; 2020 Feb; 121(1):84-89. PubMed ID: 30794883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).
    Otto S; Aljohani S; Fliefel R; Ecke S; Ristow O; Burian E; Troeltzsch M; Pautke C; Ehrenfeld M
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34065104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Refractory Medicine Related Osteonecrosis of Jaw With Piezosurgical Debridement and Autologous Platelet Rich Fibrin: Feasibility Study.
    Gurav S; Dholam KP; Singh GP
    J Craniofac Surg; 2022 May; 33(3):e226-e230. PubMed ID: 34310422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.
    Kuroshima S; Sasaki M; Murata H; Sawase T
    Gerodontology; 2019 Dec; 36(4):313-324. PubMed ID: 31373407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin.
    Özalp Ö; Yıldırımyan N; Öztürk C; Kocabalkan B; Şimşek Kaya G; Sindel A; Altay MA
    BMC Oral Health; 2021 Dec; 21(1):613. PubMed ID: 34852823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bisphosphonate-related osteonecrosis of the jaws].
    Sogacheva VV; Syomkin VA
    Stomatologiia (Mosk); 2022; 101(6):85-90. PubMed ID: 36562373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.